Nexplanon Application Post-Abortion (NAPA)

N/ACompletedNCT02037919

Family Planning Associates Medical Group, LTD148 enrolled

Overview

Women who receive Nexplanon immediately post abortion will be significantly more likely to be using the device 6 months after the procedure than those assigned to receive the device 2-4 weeks after the procedure.

Women will be contacted 6 months after their abortion to ask about contraception use and side effects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

148

Conditions

Contraception Abortion, Therapeutic

Interventions

Immediate Nexplanon InsertionOTHER

Patient will have a Nexplanon inserted within 15 minutes of her abortion

Post-op Nexplanon InsertionOTHER

Place Nexplanon at post operative visit rather than at surgery

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 18 years of age and older, * an intrauterine pregnancy \> 14 weeks and \<23 6/7 weeks gestation and desire termination of pregnancy * desire a Nexplanon for contraception * able to give informed consent in English * no contraindications to Nexplanon (based on U.S. CDC Medical Eligibility Criteria for Contraception) or D\&E Exclusion Criteria: * unable to give informed consent * have any of the following medical conditions: active venous thromboembolism, known or suspected sex-steroid sensitive malignancies, current hepatic disease with abnormal liver function tests, undiagnosed vaginal bleeding, hypersensitivity to any of the ingredients in Nexplanon. * non-surgical management of pregnancy * prior participation in this study * breast cancer or a history of breast cancer

Locations (2)

Family Planning Associates Medical Grooup, LTD

Chicago, Illinois, United States

University of Pittsburgh

Pittsburgh, Pennsylvania, United States

Outcomes

Primary Outcomes

Intention-to-treat Analysis of Etonogestrel Implant Use

Current use of Etonogestrel implant, confirmed via phone by participant palpation, at 6 months post-insertion, with all entire sample used in calculations.

Time frame: 6 months

Per-protocol Analysis of Etonogestrel Implant Use

Current use of Etonogestrel implant, confirmed via phone by participant palpation, at 6 months post-insertion, with only participants who completed the 6-month follow-up used in calculations.

Time frame: 6 months

Secondary Outcomes

Repeat Pregnancy

Occurrence of a pregnancy within 6 months after second-trimester abortion.

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.